DGDeepa Ghosh

Deepa Ghosh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Deepa Ghosh has a total of 126 co-authors. Here are the top co-authors by number of shared publications:

  • Jijo Thomas

    Chemical Biology Unit, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India

    16 shared publications
  • Vineeta Panwar

    Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Mohali 140306, Punjab, India

    14 shared publications
  • Anjana Sharma

    Chemical Biology Unit, Institute of Nano Science and Technology, Sector-81, Mohali 140306, Punjab, India

    13 shared publications
  • Vianni Chopra

    Chemical Biology Unit, Institute of Nano Science and Technology, Knowledge City, Sector 81, Mohali, Punjab 140306, India

    12 shared publications
  • Swati Kaushik

    Chemical Biology Unit Institute of Nano Science and Technology Knowledge City, Sector 81 Mohali Punjab 140306 India

    11 shared publications
  • Himadri Shekhar Roy

    Chemical Biology Unit, Institute of Nano Science and Technology, Mohali, India

    8 shared publications

Latest Publications

  • Open Access

    Transformative Materials Research: Defining Conceptual Change across Scales

    by Ranjani Viswanatha, P. S. Anil Kumar, Archita Patnaik, Deepa Ghosh, Thalappil Pradeep, Umesh V. Waghmare, D. D. Sarma

    What qualifies as transformative materials research? In this Viewpoint, we use “transformative” to denote work that forces revision of underlying assumptions, enables generalization across systems, or reveals regimes inaccessible to existing frameworks. The term is widely invoked yet rarely defined with disciplinary precision. Perspectives spanning nanomaterials chemistry, catalysis, soft and bioinspired interfaces, and functional materials suggest that transformation occurs when new reaction mechanisms are uncovered, when structure–property relationships are redefined, and when operation under realistic chemical environments reveals fundamentally new governing mechanisms. Foundational insight, developmental refinement, and industrial realization constitute an interdependent value chain through which transformative discoveries mature into societal impact. Mistaking progress within a single component for a fundamental shift risks blurring the line between incremental refinement and genuine conceptual change. Transformation requires a conceptual discontinuity in at least one stage of this value chain, most commonly through foundational scientific insight, while the remaining stages enable its realization and broader impact. This Viewpoint argues that transformative materials research is defined less by topic than by intellectual pursuit, chemical and structural rigor, and sustained engagement with unexpected observations during mechanism discovery and eventual validation under realistic chemical environments and at scale.

  • Injectable polysaccharide-based composite hydrogel promotes regeneration of critical-sized bone defects

    by Malika Arora, Satish Kumar, Jijo Thomas, Preethi Murugesan, Saurabh Chawla, Chandan Goswami, Chirag Kulkarni, Naibedya Chattopadhyay, Deepa Ghosh


  • Engineering osteoinductive hydroxyapatite via zinc and strontium co-substitution

    by Sivaraj Durairaj, Malika Arora, Satish Kumar, Preethi Murugesan, Juan F. Vivanco, Deepa Ghosh

    Critical-size bone defects remain a major clinical challenge due to the limited regenerative capacity of bone tissue, necessitating biomaterials that provide both structural support and biological stimulation. Synthetic hydroxyapatite (HAp) is widely used for bone repair because of its close similarity to native bone minerals; however, strategies to enhance its biological performance are actively being explored. Among these, ionic substitution—particularly with zinc (Zn2+) and strontium (Sr2+) ions—has emerged as a promising approach to promote osteogenesis while inhibiting bone resorption. Recent studies on Zn/Sr-substituted HAp have reported the formation of undesirable secondary phases, which compromise biological performance. Considering these limitations, the present study aims to synthesize phase-pure Zn- and Sr-substituted hydroxyapatite nanoparticles using a soft-template method, with careful optimization of Zn2+ and Sr2+ concentrations for bone tissue engineering applications. Accordingly, Zn-substituted, Sr-substituted, and Zn/Sr co-substituted hydroxyapatite nanoparticles (Zn-HAp, Sr-HAp, and ZnSr-HAp) were synthesised and systematically characterised. Physicochemical analysis revealed that, in comparison with single-ion substitution, Zn/Sr co-substitution significantly altered crystal nucleation and growth behaviour while preserving phase purity. Biological evaluation using bone-derived cells demonstrated that ZnSr-HAp nanoparticles were highly biocompatible and significantly enhanced cell attachment, proliferation, and matrix mineralisation compared to pristine and single ion-substituted HAp. Furthermore, ZnSr-HAp treatment markedly upregulated the expression of collagen type I (COL I) and osteocalcin (OCN), indicating the promotion of both early extracellular matrix formation and late-stage osteogenic maturation. Collectively, these findings demonstrate a synergistic effect of Zn and Sr co-substitution in enhancing the osteoinductive and osteoconductive properties of HAp. Overall, Zn/Sr co-substituted hydroxyapatite nanoparticles represent a promising bioactive platform for advanced bone regeneration applications.


  • Curcumin monoglucuronide protects cartilage from progressive degeneration by blocking MMP-13

    by Himadri Shekhar Roy, Chirag Kulkarni, K. M. Neethu, Anand Babu, Malika Arora, Govindasamy Jayamurugan, Dipankar Mandal, Rajdeep Guha, Naibedya Chattopadhyay, Deepa Ghosh

    Collagenases (MMP-1, MMP-8, and MMP-13) play significant roles in the pathophysiology of osteoarthritis. Among these proteins, MMP-13 and MMP-8 are known for their catabolic roles in the degradation of the articular cartilage matrix. Using computational studies, we had previously observed that a metabolite of curcumin, Curcumin monoglucuronide (CMG), binds to MMPs involved in cartilage matrix destruction. The purpose of this study was to confirm the ability of CMG to protect cartilage by blocking the activity of these enzymes. The ability of CMG to bind and block the activities of MMP-13 and MMP-8 was established using several physicochemical methods. First, the protective effect of CMG on MMP-mediated cartilage destruction was demonstrated using cartilage explants in vitro. Second, the in vivo efficacy of CMG was tested by comparison with BI-4394, a specific MMP-13 inhibitor, using a rat anterior cruciate ligament transection (ACLT) model. These studies demonstrated that CMG was more effective than BI-4394 at preventing cartilage degeneration. In separate in vitro studies, CMG did not affect chondrocyte proliferation or the expression of NF-κB-mediated proinflammatory genes. Together, these findings demonstrate the therapeutic potential of CMG and emphasize the importance of inhibiting both MMP-13 and MMP-8 to achieve improved clinical outcomes.


  • Carbon Nanotubes for Cartilage and Bone Tissue Engineering

    by Sivaraj Durairaj, Himadri Shekhar Roy, Malika Arora, Keshav Kant Ahuja, Deepa Ghosh


  • Unveiling the Mechanistic Aspects of Solar-Driven Hematein Remediation Using Biocompatible Metal-Free Carbon Nitride Nanosheets

    by Sivaraj Durairaj, Himanshu Bhatt, Preethi Murugesan, Navita Salaria, Malika Arora, Hirendra N. Ghosh, Deepa Ghosh


  • Nanotechnology Advancements for Improved Bone Metabolism, Regeneration and Treatment of Bone Diseases

    by Vianni Chopra, Diana Arredondo Bernal, Gaurav Chauhan, Sergio Omar Martinez Chapa, Deepa Ghosh

    The advent of technology has opened various avenues to study the effect of nanomedicine in the area of bone regeneration. The active or passive targeting of nanomedicine has been utilized to mechanistically elucidate the cellular metabolism pathways, as well as regeneration cascades. The use of biomaterials at nanoscale levels as scaffolds and for drug targeting has also led to the development of new strategies to visualize and recapitulate the microscopic and nanoscopic regeneration of bone. Apart from regeneration, the use of nanocarriers to deliver drugs and active molecules has also seen a wide application in bone-related diseases including, bone cancer, bone tuberculosis, osteoporosis, osteoarthritis, osteomyelitis and others. This chapter provides insight into the role of nanotechnology in bone metabolism, regeneration and disease conditions.

  • Silver Nanoparticle-Embedded Carbon Nitride: Antifungal Activity on Candida albicans and Toxicity toward Animal Cells

    by Ganeshkumar Arumugam, Sivaraj Durairaj, Juliana Caparroz Gonçale, Paulo Henrique Fonseca Do Carmo, Maíra Terra Garcia, Newton Soares da Silva, Bruno Montanari Borges, Flavio Vieira Loures, Deepa Ghosh, Juan F. Vivanco, et al.

    The development of engineered nanomaterials has been considered a promising strategy to control oral infections. In this study, silver-embedded carbon nitrides (Ag@g-CN) were synthesized and tested against Candida albicans, investigating their antifungal action and biocompatibility in animal cells. Ag@g-CN was synthesized by a simple one-pot thermal polymerization technique and characterized by various analytical techniques. X-ray diffraction (XRD) analysis revealed slight alterations in the crystal structure of g-CN upon the incorporation of Ag. Fourier transform infrared (FT-IR) spectroscopy confirmed the presence of Ag-N bonds, indicating successful silver incorporation and potential interactions with g-CN's amino groups. UV-vis spectroscopy demonstrated a red shift in the absorption edge of Ag@g-CN compared with g-CN, attributed to the surface plasmon resonance effect of silver nanoparticles. Field emission scanning electron microscopy (FE-SEM) and transmission electron microscopy (TEM) confirmed the 2D layered sheet like morphology of both materials. The Ag 3d peaks found in X-ray photoelectron spectroscopy (XPS) confirmed the presence of metallic Ag0 nanoparticles in Ag@g-CN. The Ag@g-CN materials exhibited high antifungal activity against reference and oral clinical strains of C. albicans, with minimal inhibitory concentration (MIC) ranges between 16-256 μg/mL. The mechanism of Ag@g-CN on C. albicans was attributed to the disruption of the membrane integrity and disturbance of the biofilm. In addition, the Ag@g-CN material showed good biocompatibility in the fibroblastic cell line and in Galleria mellonella, with no apparent cytotoxicity observed at a concentration up to 1000 μg/mL. These findings demonstrate the potential of the Ag@g-CN material as an effective and safe antifungal agent for the treatment of oral fungal infections.


  • Open Access

    On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis

    by Himadri Shekhar Roy, Preethi Murugesan, Chirag Kulkarni, Malika Arora, Geet Kumar Nagar, Rajdeep Guha, Naibedya Chattopadhyay, Deepa Ghosh

    Release of BI-4394, a MMP-13 inhibitor, from an enzyme-responsive hydrogel protects cartilage from progressive degeneration in an ACLT rat model.